Our Collaborations

Scroll to explore

Collaboration : a key component of Domain’s DNA

We collaborate with pharmaceutical and biotech companies to advance GPCR drug discovery assets, not only in immuno-oncology, but also in the fields of CNS and rare diseases, in order to bring innovative solutions toward the clinic. Learn more about our latest collaborations here.


GPCR target for metabolic diseases

Discover more
Logo RHU Condor against Sarcoma

Precision Medicine and Immunotherapy of Sarcoma

Discover more

Multi-target collaboration for rare diseases

Discover more

CXCR4 biased agonist

Discover more